Growth Metrics

Pfizer (PFE) Shareholder's Equity (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 4.19%
Dec 31, 2025 -7.11%
Sep 28, 2025 4.59%
Jun 29, 2025 -1.79%
Mar 30, 2025 2.42%
Dec 31, 2024 -4.39%
Sep 29, 2024 5.21%
Jun 30, 2024 -4.95%
Mar 31, 2024 3.66%
Dec 31, 2023 -8.14%
Oct 1, 2023 -2.10%
Jul 2, 2023 -1.92%
Apr 2, 2023 5.55%
Dec 31, 2022 3.26%
Oct 2, 2022 6.20%
Jul 3, 2022 5.79%
Apr 3, 2022 6.74%
Dec 31, 2021 115.27%
Oct 3, 2021 -48.82%
Jul 4, 2021 2.11%
Apr 4, 2021 8.49%
Dec 31, 2020 85.84%
Sep 27, 2020 -47.11%
Jun 28, 2020 -1.18%
Mar 29, 2020 2.99%
Dec 31, 2019 79.72%
Sep 29, 2019 -41.09%
Jun 30, 2019 1.29%
Mar 31, 2019 -7.21%
Dec 31, 2018 -11.03%
Sep 30, 2018 2.20%
Jul 1, 2018 -0.59%
Apr 1, 2018 -1.56%
Dec 31, 2017 17.26%
Oct 1, 2017 4.12%
Jul 2, 2017 0.44%
Apr 2, 2017 -2.35%
Dec 31, 2016 -5.91%
Oct 2, 2016 1.33%
Jul 3, 2016 -0.91%
Apr 3, 2016 -2.54%
Dec 31, 2015 -2.75%
Sep 27, 2015 -0.08%
Jun 28, 2015 -1.03%
Mar 29, 2015 -5.63%
Dec 31, 2014 -8.53%
Sep 28, 2014 1.75%
Jun 29, 2014 -1.05%
Mar 30, 2014 1.50%
Dec 31, 2013 -2.21%
Sep 29, 2013 -0.25%
Jun 30, 2013 -4.50%
Mar 31, 2013 0.70%
Dec 31, 2012 -0.03%
Sep 30, 2012 2.71%
Jul 1, 2012 -4.45%
Apr 1, 2012 0.77%
Dec 31, 2011 -8.25%
Oct 2, 2011 1.77%
Jul 3, 2011 -1.76%
Apr 3, 2011 2.04%
Dec 31, 2010 0.72%
Oct 3, 2010 1.38%
Jul 4, 2010 -4.04%
Apr 4, 2010 -0.40%
Dec 31, 2009 36.71%
Sep 27, 2009 4.94%